Sponsor:
SystImmune Inc.
Code:
NCT07940881
Conditions
Locally Advanced /Metastatic Solid Tumors
Locally Advanced / Metastatic Solid Tumors
First in Human
Metastatic Solid Cancers
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SI-B037
Brief summary:
Conditions
Locally Advanced /Metastatic Solid Tumors
Locally Advanced / Metastatic Solid Tumors
First in Human
Metastatic Solid Cancers
Non Small Cell Lung Cancer
Study ID
NCT07940881
Start date
Aug 24, 2026
Status verified date
Nov, 2026
Completion date
Nov, 2029
Anticipated
Primary completion date
Nov, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
400 participants
Anticipated
Intervention Model
Sequential
Primary purpose
Treatment
Arms
experimental: Experimental: Experimental SI-B037
Interventions
SI-B037
Primary outcome measure
Central contacts
Locations
NEXT Oncology
Recruiting
Houston, Texas, United States, 77054
Contacts
NEXT Oncology Study Coordinator
210-568-4397Sponsor
SystImmune Inc.
Last update posted
Nov 17, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by SystImmune Inc. on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.